Rituximab Supplier-Buyer Network — Trade Flow Analysis

Name: Rituximab Supplier-Buyer Trade Network Dataset — 164+ Indian Exporters, 17+ Importers, 104+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Rituximab supplier network, Rituximab buyers, pharmaceutical export India, Rituximab trade data

TransData Nexus

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Who Supplies Rituximab? Top Manufacturers & Buyers 2026 — DR.REDDY'S LABORATORIES LTD Leads | TransData Nexus | TransData Nexus

1DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the first-largest Rituximab exporter from India, with a market share of 27.5% and a total export value of $5.3M across 64 shipments. Their average shipment value of $82.1K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 83.5% of this supplier's tracked business. Top customers include:

• JSC R-PHARM — $4.4M across 53 shipments (83.5% of this supplier's total exports)

• DR.REDDYS LABORATORIES PHILIPPINES — $358.7K across 4 shipments (6.8% of this supplier's total exports)

• NA — $254.1K across 3 shipments (4.8% of this supplier's total exports)

• HEALTHCARE PHARMACEUTICALS LTD., — $160.7K across 2 shipments (3.1% of this supplier's total exports)

• UPS WAREHOUSE — $95.8K across 1 shipments (1.8% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $82.1K is 422% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

2DR REDDYS LABORATORIES LIMITED

DR REDDYS LABORATORIES LIMITED is the second-largest Rituximab exporter from India, with a market share of 13.8% and a total export value of $2.6M across 11 shipments. Their average shipment value of $239.5K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 91.5% of this supplier's tracked business. Top customers include:

• JSC R-PHARM — $2.4M across 10 shipments (91.5% of this supplier's total exports)

• UPS WAREHOUSE — $202.1K across 1 shipments (7.7% of this supplier's total exports)

• PT FERRON PAR PHARMA — $14.2K across 0 shipments (0.5% of this supplier's total exports)

• HYPERPHARM LTD — $7.9K across 0 shipments (0.3% of this supplier's total exports)

• JSC R-PHARM — $468 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $239.5K is 1422% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

3RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the third-largest Rituximab exporter from India, with a market share of 11.0% and a total export value of $2.1M across 102 shipments. Their average shipment value of $20.6K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• STATE PHARMACEUTICALS CORPORATION O — $596.8K across 29 shipments (28.5% of this supplier's total exports)

• LABORATORIOS LEGRAND S.A — $583.5K across 28 shipments (27.8% of this supplier's total exports)

• ABC PHARMA SERVICES (PVT) LTD — $430.6K across 21 shipments (20.5% of this supplier's total exports)

• DROGUERIA MK LAB S.A.C — $243.6K across 12 shipments (11.6% of this supplier's total exports)

• LABORATORIOS LEGRAND S.A — $242.5K across 12 shipments (11.6% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $20.6K is 31% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

4MEDWISE OVERSEAS PRIVATE LIMITED

MEDWISE OVERSEAS PRIVATE LIMITED is the fourth-largest Rituximab exporter from India, with a market share of 5.7% and a total export value of $1.1M across 5 shipments. Their average shipment value of $216.3K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

MEDWISE OVERSEAS PRIVATE LIMITED serves 2 named buyers in our database. TO is the dominant customer, accounting for 53.9% of this supplier's tracked business. Top customers include:

• TO — $583.1K across 3 shipments (53.9% of this supplier's total exports)

• TO — $498.3K across 2 shipments (46.1% of this supplier's total exports)

Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $216.3K is 1275% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

5HETERO BIOPHARMA LIMITED

HETERO BIOPHARMA LIMITED is the fifth-largest Rituximab exporter from India, with a market share of 4.7% and a total export value of $901.0K across 8 shipments. Their average shipment value of $112.6K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

HETERO BIOPHARMA LIMITED serves 5 named buyers in our database. XXAROXXPHAXXA SXX DXXC V is the dominant customer, accounting for 66.3% of this supplier's tracked business. Top customers include:

• XXAROXXPHAXXA SXX DXXC V — $597.2K across 5 shipments (66.3% of this supplier's total exports)

• XX SAXXE FXXMA — $128.7K across 1 shipments (14.3% of this supplier's total exports)

• XXVENXXHARXX S XXC — $76.3K across 1 shipments (8.5% of this supplier's total exports)

• XXVANXXD CXXMICXX IN — $57.7K across 1 shipments (6.4% of this supplier's total exports)

• XXCEPXX PHXXMACXXTIC — $41.1K across 0 shipments (4.6% of this supplier's total exports)

Key Insight: HETERO BIOPHARMA LIMITED's per-shipment value of $112.6K is 616% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

6INVEX HEALTH PRIVATE LIMITED

INVEX HEALTH PRIVATE LIMITED is the fifth-largest Rituximab exporter from India, with a market share of 1.1% and a total export value of $202.1K across 3 shipments. Their average shipment value of $67.4K is above the market average of $15.7K, suggesting premium or bulk contract pricing.

INVEX HEALTH PRIVATE LIMITED serves 2 named buyers in our database. AFRI FARMACIA is the dominant customer, accounting for 70.8% of this supplier's tracked business. Top customers include:

• AFRI FARMACIA — $143.2K across 2 shipments (70.8% of this supplier's total exports)

• World Health Organiz — $59.0K across 1 shipments (29.2% of this supplier's total exports)

Key Insight: INVEX HEALTH PRIVATE LIMITED's per-shipment value of $67.4K is 328% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.

1Russia

Russia ranks as the first-largest destination for Rituximab imports from India, with a total trade value of $9.0M across 11 shipments — representing a 47.2% share of all Rituximab exports. The average shipment value of $820.3K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Rituximab importers in Russia: JSC R-PHARM is the largest buyer, accounting for 73.3% ($6.6M) of this market's total imports.

• JSC R-PHARM — $6.6M (73.3% of Russia's total)

Key Insight: Russia's per-shipment average of $820.3K (5114% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Rituximab imports from India.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka ranks as the second-largest destination for Rituximab imports from India, with a total trade value of $2.2M across 19 shipments — representing a 11.3% share of all Rituximab exports. The average shipment value of $113.7K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Rituximab importers in Sri Lanka: STATE PHARMACEUTICALS CORPORATION is the largest buyer, accounting for 38.9% ($839.8K) of this market's total imports.

• STATE PHARMACEUTICALS CORPORATION — $839.8K (38.9% of Sri Lanka's total)

• STATE PHARMACEUTICALS CORPORATION O — $596.8K (27.6% of Sri Lanka's total)

• ABC PHARMA SERVICES (PVT) LTD — $430.6K (19.9% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $113.7K (623% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Rituximab imports from India.

Primary Market

Secondary Market

3Colombia

Colombia ranks as the third-largest destination for Rituximab imports from India, with a total trade value of $1.2M across 10 shipments — representing a 6.1% share of all Rituximab exports. The average shipment value of $117.4K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Rituximab importers in Colombia: LABORATORIOS LEGRAND S A is the largest buyer, accounting for 49.7% ($583.5K) of this market's total imports.

• LABORATORIOS LEGRAND S A — $583.5K (49.7% of Colombia's total)

• LABORATORIOS LEGRAND S.A — $376.4K (32.1% of Colombia's total)

Key Insight: Colombia's per-shipment average of $117.4K (646% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Colombia is a key market for Rituximab imports from India.

Primary Market

Secondary Market

4Venezuela

Venezuela ranks as the fourth-largest destination for Rituximab imports from India, with a total trade value of $1.1M across 0 shipments — representing a 5.7% share of all Rituximab exports. The average shipment value of $1.1M is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations.

Key Insight: Venezuela's per-shipment average of $1.1M (6794% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Venezuela is a key market for Rituximab imports from India.

Primary Market

Secondary Market

5Mexico

Mexico ranks as the fifth-largest destination for Rituximab imports from India, with a total trade value of $719.8K across 2 shipments — representing a 3.8% share of all Rituximab exports. The average shipment value of $359.9K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Rituximab importers in Mexico: XXAROXXPHAXXA SXX DXXC V is the largest buyer, accounting for 83.0% ($597.2K) of this market's total imports.

• XXAROXXPHAXXA SXX DXXC V — $597.2K (83.0% of Mexico's total)

Key Insight: Mexico's per-shipment average of $359.9K (2188% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Rituximab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Rituximab.
2.Flow Mapping: 164 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,215 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,215 Verified Shipments

164 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Rituximab

Rituximab

Who Supplies Rituximab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Rituximab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Rituximab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1DR.REDDY'S LABORATORIES LTD

2DR REDDYS LABORATORIES LIMITED

3RELIANCE LIFE SCIENCES PRIVATE LIMITED

4MEDWISE OVERSEAS PRIVATE LIMITED

5HETERO BIOPHARMA LIMITED

6INVEX HEALTH PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Rituximab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Rituximab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Sri Lanka

3Colombia

4Venezuela

5Mexico

People Also Ask — Rituximab Supplier & Trade Network

Rituximab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology